VIM and malignant colon neoplasm: Based on the expression of vimentin, five colon cancer cells were selected for further studies: (1) low-expressing group: HCT-15 and Colo205; (2) medium-expressing group: HT29 and LoVo; and (3) high-expressing group: SW480.